69 patients ( median age 53 years , 19-79 years old ) with untreated acute non-lymphoblastic leukemia ( anll ) were randomized to receive either a regimen of amsacrine , cytarabine , thioguanine ( aat ) or daunorubicin , cytarabine , thioguanine ( dat ) .
C0023467
anll
C0011015
daunorubicin